Delving into the Latest Updates on Benxi Economic Development Zone Kangmaisi Pharmaceutical Co., Ltd. with Synapse

Overview

Tags

Immune System Diseases

Digestive System Disorders

Hemic and Lymphatic Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Hemic and Lymphatic Diseases	1
Immune System Diseases	1
Neoplasms	1

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

DNA x Top II	1

本试验的目的是探索淋巴示踪用盐酸米托蒽醌注射液对胃癌患者淋巴示踪的有效性、安全性和耐受性并确定试验用药物最优使用剂量范围，同时探索淋巴示踪用盐酸米托蒽醌注射液对胃癌患者的药代动力学特征，为III 期临床试验的用药剂量及评价指标提供合理依据。

[Translation]

The purpose of this trial is to explore the efficacy, safety and tolerability of mitoxantrone hydrochloride injection for lymphatic tracing in patients with gastric cancer and determine the optimal dosage range of the trial drug. At the same time, it is to explore the pharmacokinetic characteristics of mitoxantrone hydrochloride injection for lymphatic tracing in patients with gastric cancer, and to provide a reasonable basis for the dosage and evaluation indicators of the Phase III clinical trial.

Start Date01 Sep 2020

Sponsor / Collaborator

Shenyang Xintager Pharmaceutical Technology Development Co., Ltd.

[+2]

CTR20192435 / CompletedPhase 2/3

淋巴示踪用盐酸米托蒽醌注射液用于乳腺癌手术前哨淋巴结示踪的有效性和安全性的多中心、阳性、自身对照临床

[Translation] A multicenter, positive, self-controlled clinical trial of the efficacy and safety of mitoxantrone hydrochloride injection for sentinel lymph node tracing before breast cancer surgery

评价试验药物对乳腺癌受试者前哨淋巴结示踪的有效性与安全性。

[Translation]

To evaluate the effectiveness and safety of investigational drugs in sentinel lymph node tracing in subjects with breast cancer.

Start Date11 Dec 2019

Sponsor / Collaborator

Shenyang Xintager Pharmaceutical Technology Development Co., Ltd.

[+2]

CTR20171136 / CompletedPhase 1

MMT注射液用于乳腺癌淋巴示踪的单中心、阳性、自身对照I期临床试验

[Translation] A single-center, positive, self-controlled phase I clinical trial of MMT injection for lymph node tracing in breast cancer

本试验的目的是评价MMT注射液对乳腺癌患者淋巴结示踪的安全性和探索试验用药物最优使用剂量与使用方法及有效性。

[Translation]

The purpose of this trial is to evaluate the safety of MMT injection in lymph node tracing in patients with breast cancer and to explore the optimal dosage, method of use and effectiveness of the trial drug.

Start Date13 Dec 2017

Sponsor / Collaborator

Shenyang Xintager Pharmaceutical Technology Development Co., Ltd.

[+2]

100 Clinical Results associated with Benxi Economic Development Zone Kangmaisi Pharmaceutical Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Benxi Economic Development Zone Kangmaisi Pharmaceutical Co., Ltd.

Login to view more data

100 Deals associated with Benxi Economic Development Zone Kangmaisi Pharmaceutical Co., Ltd.

Login to view more data

100 Translational Medicine associated with Benxi Economic Development Zone Kangmaisi Pharmaceutical Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 3 Clinical

1

Login to view more data